Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease? (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/jpd-219008
PubMed Identifier: 34334425
Publication URI: http://europepmc.org/abstract/MED/34334425
Type: Journal Article/Review
Parent Publication: Journal of Parkinson's Disease
Issue: 3
ISSN: 1877-7171